Major Adverse Cardiovascular Events According to Thrombolysis in Myocardial Infarction Flow Grade and Intervention Timing Before Percutaneous Coronary Intervention in Non–ST-Segment Elevation Myocardial Infarction

1. Puymirat, E, Simon, T, Cayla, G, et al. Acute myocardial infarction: changes in patient characteristics, management, and 6-month outcomes over a period of 20 years in the fast-mi program (french registry of acute st-elevation or non-st-elevation myocardial infarction) 1995 to 2015. Circulation 2017; 136(20): 1908–1919.
Google Scholar | Crossref | Medline2. Chan, MY, Sun, JL, Newby, LK, et al. Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation 2009; 119(24): 3110–3117.
Google Scholar | Crossref3. Song, YB, Hahn, JY, Kim, JH, et al. Comparison of angiographic and other findings and mortality in non-ST-segment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention. Am J Cardiol 2010; 106(10): 1397–1403.
Google Scholar | Crossref4. Kim, YH, Her, AY, Jeong, MH, et al. Two-year clinical outcomes according to pre-pci timi flow grade and reperfusion timing in non-stemi after newer-generation drug-eluting stents implantation. Angiology 2021; DOI: 10.1177/00033197211012537.
Google Scholar | SAGE Journals5. Zeymer, U, Huber, K, Fu, Y, et al. Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study. Eur Heart J Acute Cardiovasc Care 2012; 1(2): 136–142.
Google Scholar | SAGE Journals6. De Luca, G, Brener, SJ, Mehran, R, et al. Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: insights from the ACUITY trial. Int J Cardiol 2013; 167(3): 727–732.
Google Scholar | Crossref7. Zhang, Y, Gao, C, Liu, H, et al. Routine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Clin Exp Pharmacol Physiol 2013; 40(4): 289–294.
Google Scholar | Crossref8. Lemesle, G, Laine, M, Pankert, M, et al. Optimal timing of intervention in nste-acs without pre-treatment: the early randomized trial. JACC Cardiovasc Interv 2020; 13(8): 907–917.
Google Scholar | Crossref9. Case, BC, Yerasi, C, Wang, Y, et al. Admissions rate and timing of revascularization in the united states in patients with non-st-elevation myocardial infarction. Am J Cardiol 2020; 134: 24–31.
Google Scholar | Crossref10. Arora, S, Matsushita, K, Qamar, A, Stacey, RB, Caughey, MC. Early versus late percutaneous revascularization in patients hospitalized with non ST-segment elevation myocardial infarction: the atherosclerosis risk in communities surveillance study. Catheter Cardiovasc Interv 2018; 91(2): 253–259.
Google Scholar | Crossref11. Sim, DS, Jeong, MH, Ahn, Y, et al. Clinical impact of immediate invasive strategy in patients with non-ST-segment elevation myocardial infarction. Int J Cardiol 2016; 221: 937–943.
Google Scholar | Crossref12. Jobs, A, Mehta, SR, Montalescot, G, et al. Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials. Lancet 2017; 390(10096): 737–746.
Google Scholar | Crossref | Medline13. D’Ascenzo, F, Biondi-Zoccai, G, Moretti, C, et al. TIMI, GRACE and alternative risk scores in acute coronary syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials 2012; 33(3): 507–514.
Google Scholar | Crossref | Medline | ISI14. Bailleul, C, Aissaoui, N, Cayla, G, et al. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: results from the FAST-MI 2010 registry. Arch Cardiovasc Dis 2018; 111(2): 101–108.
Google Scholar | Crossref15. Joost, A, Stiermaier, T, Eitel, C, et al. Impact of initial culprit vessel flow on infarct size, microvascular obstruction, and myocardial salvage in acute reperfused st-elevation myocardial infarction. Am J Cardiol 2016; 118(9): 1316–1322.
Google Scholar | Crossref16. Schaaf, MJ, Mewton, N, Rioufol, G, et al. Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patients. J Cardiol 2016; 67(3): 248–253.
Google Scholar | Crossref

留言 (0)

沒有登入
gif